Close
Digital Health & Ai Innovation summit 2026
Medical Taiwan 2026

Bumrungrad International Hospital is First to Achieve GHA’s COVID-19 Certification of Conformance for Medical Travel

Bumrungrad International Hospital is First to Achieve GHA's COVID-19 Certification of Conformance for Medical Travel

Bumrungrad International Hospital, one of the World’s top choices for traveling patients, located in Bangkok, Thailand, is the first hospital in the world to be awarded Global Healthcare Accreditation’s Certification of Conformance with COVID-19 Guidelines for Medical Travel Programs.

The Global Healthcare Accreditation (GHA) Program For Medical Travel Services issued the free Guidelines in early July of this year to assist organizations in the medical tourism and health tourism industries seeking to mitigate the risk of COVID-19 infection for both domestic and traveling patients and their companions. The guidelines are unique in that they focus on the entire care continuum, including providing guidance for travel, as well as interactions with the healthcare organization, hotel and ground transportation.

Ms. Artirat Charukitpipat, Bumrungrad’s Chief Executive Officer stated, “From the very start of the spread of the coronavirus, Bumrungrad moved quickly to implement internal, as well as national and international protocols and guidelines designed to mitigate the risk of COVID-19 infection for patients and staff. While the pandemic continues to be an ongoing challenge, I am extremely proud of the work our entire team has done and continues to do to keep patients and staff safe. Achieving GHA’s Certification of Conformance with COVID-19 Guidelines for Medical Travel Programs is a very important step for us to help increase patient trust in our medical travel services and also to validate the work we are doing to keep medical travelers safe during this difficult time.”

The Certification of Conformance (https://www.globalhealthcareaccreditation.com/certification-of-conformance-with-gha-covid-19-guidelines-for-medical-travel-programs) for hospitals and ambulatory centers is a three-year Certification with annual reviews, which signals to medical travelers, referrers, and other payers that the organization has implemented the recommendations in the guidelines as a proactive risk mitigation strategy to ensure patient safety and wellbeing during and post-COVID-19.

According to Karen Timmons, Chief Executive Officer, Global Healthcare Accreditation (GHA), “The COVID-19 Certification of Conformance provides a seal to patients, buyers and other key stakeholders demonstrating that a medical travel program’s operational protocols, practices and procedures have undergone an external review and reflect international best practices designed to keep traveling patients safe. One of the key objectives of the Certification of Conformance is to enhance transparency and encourage ongoing communications with patients, which is even more important during this challenging time, and which ultimately helps to increase patient trust in the organization. We congratulate Bumrungrad International Hospital as the first hospital in the world to achieve the GHA’s Certification of Conformance and for its unwavering commitment to patient safety.”

The Global Healthcare Accreditation (GHA) Program For Medical Travel Services Guidelines (https://www.globalhealthcareaccreditation.com/gha-covid-19-guidelines) are free and the Certification of Conformance (https://www.globalhealthcareaccreditation.com/certification-of-conformance-with-gha-covid-19-guidelines-for-medical-travel-programs) is a process that is accomplished virtually and usually within a three to six week period of time. For more information about the Global Healthcare Accreditation (GHA) program and/or the COVID-19 Guidelines for Medical Travel Programs email Info@GHACCREDITATION.COM or Call U.S. +1 561 228 4014.

About GHA

Founded in 2016, the Global Healthcare Accreditation for Medical Travel Services is the only accrediting body focused solely on medical travel services. GHA’s international standards and professional norms for medical travel were developed in consultation with leading global experts in the industry, including providers, insurers and employers committed to establish best practices in medical tourism and health tourism, which support healthcare providers in validating quality and patient experience, increasing visibility, and implementing a sustainable business model for providers along the entire medical travel care continuum. GHA received ISQua’s International Society for Quality in Health Care External Evaluation Association (IEEA) accreditation in 2019.

Bumrungrad International Hospital is an internationally accredited, multi-specialty hospital located in the heart of Bangkok, Thailand. Founded in 1980 and listed on the Stock Exchange of Thailand in 1989, it is one of the largest private hospitals in Southeast Asia. Bumrungrad International serves 1.1 million patients annually, including over half a million international patients from 190 different countries.

Cone Health to Merge with Sentara Healthcare Totaling $11B in Assets

Cone Health to Merge with Sentara Healthcare Totaling $11B in Assets

Cone Health has signed a letter of intent to merge with Norfolk, Virginia-based Sentara Healthcare. The merger will create a combined organization with a unique value-based approach that is focused on keeping people healthy and well, while providing high-quality, accessible and affordable health care in more ways and in more places. The Cone Health Board of Trustees voted unanimously to move forward with this letter of intent.

Cone Health, a not-for-profit integrated healthcare network consists of five hospitals in North Carolina. The system employs more than 13,000 people, including nearly more than 600 physicians and advanced practice providers, and operates more than 100 care sites. Its Medicare Advantage health plan, HealthTeam Advantage serves 15,000 members.

“Cone Health is among the highest-quality health care organizations in the nation, and we are financially strong. With the right partner, we can build on what we’ve created and do even more for those we are privileged to serve,” says Terry Akin, CEO, Cone Health. “We have long said that Cone Health doesn’t intend to grow simply for the sake of growth. Instead, we are partnering for inspiring possibilities.”

Sentara Healthcare is an integrated, not-for-profit system comprised of 12 hospitals in Virginia and Northeastern North Carolina. The health system employs more than 1,200 physicians and advanced practice clinicians, 30,000 team members and operate hundreds of sites of care. Our Optima Health Plan and Virginia Premier Health Plan serve 858,000 members in Virginia, North Carolina and Ohio.

Merger Impact for Community

The resulting organization would have a combined $11B in assets, with Sentara representing about $8.7 billion in assets and Cone Health representing $2.8B in total assets, according to 2019 audited statements.

The communities served by Cone Health and Sentara do not overlap. As a result, the combined organization will ensure that consumers have more choices for healthcare and insurance plans, not fewer. The merger will deliver healthcare in more ways and more places with more options to pay for it.

“This rapidly changing healthcare environment requires tremendous transformation and innovation to ensure the long-term success of each respective health system and, most importantly, the very best for those we are privileged to serve,” said Howard P. Kern, president and chief executive officer of Sentara Healthcare. “We can either react to change, or we can shape it. We are choosing to shape change and will lead this transformation of healthcare together.”

Next Steps

Howard P. Kern will oversee the combined organization and the corporate headquarters will remain in Norfolk, Va., and Greensboro, N.C., will serve as the regional headquarters for the Cone Health division. Terry Akin will remain in Greensboro as the president of the Cone Health division. Cone Health representatives will join the Sentara Healthcare board, with membership on all board committees and meaningful roles in all aspects of governance. Additionally, there will continue to be a Cone Health Regional Board that will be composed of community members, medical staff and Sentara representation.

The combined organization is subject to state and federal regulatory review and customary closing conditions and is anticipated to close in mid-2021. Following that, it is expected to take up to two years to fully combine and integrate.

Waystar Acquires Medicare RCM Company eSolutions at $1.3B Valuation

Waystar Acquires Medicare RCM Company eSolutions at $1.3B Valuation

Waystar, a provider of healthcare payments software, announced a definitive agreement to acquire Francisco Partners-backed eSolutions, a revenue cycle technology company with unique Medicare-specific solutions at a $1.3B valuation, according to sources close to the deal. In bringing these two industry leaders together, Waystar will be the first technology to unite both commercial and government payers onto a single payments platform. The transaction is expected to close later this year, subject to customary conditions and approvals.

eSolutions Background

Founded in 1999, eSolutions’ technology maximizes revenue collection, accelerates cash flow, and reduces administrative burden across numerous sites of care. The company has over 6,000 payer connections and maintains a powerful and growing data set of billions of transactions. In addition to hospitals and ambulatory providers, eSolutions has deep expertise in serving the post-acute market across the entire revenue cycle, including skilled nursing, senior living facilities, home care, hospice, federally qualified healthcare centers (FQHCs), and durable medical equipment providers. eSolutions is backed by Francisco Partners.

“eSolutions is thrilled to be joining forces with Waystar, a company like ours that relentlessly focuses on delivering exceptional customer service,” said Gerry McCarthy, Chief Executive Officer of eSolutions. “The combination of our technology platforms and data solves a major pain point in revenue cycle management to drive stronger results for our clients, partners, and for healthcare.”

Acquisition Creates Unified Healthcare Payments Platform

Medicare has become the largest payer in the United States and as baby boomers age, the mix of insurance coverage is increasingly shifting to Medicare. Historically, providers have had to leverage two different systems – one to handle commercial claims, and another to handle Medicare. For healthcare providers, leveraging a single, end-to-end platform to manage both private and government payments solves a major pain point and creates significant efficiencies, freeing up time to deliver care.

“Together, Waystar and eSolutions will deliver unprecedented innovation to the industry, helping healthcare organizations accelerate revenue collection while reducing administrative expenses and repetitive tasks,” said Matthew Hawkins, Chief Executive Officer and board member of Waystar. “Uniting our companies’ data sets will further power Waystar Hubble, our artificial intelligence solution, providing access to even greater insights and value for our clients. We have long-admired eSolutions for its unique Medicare-specific revenue cycle capabilities, which are a perfect complement to the Waystar platform. We are excited to move forward as one team.”

6th Waystar Acquisition Since 2018

Waystar has integrated several other transformational technologies onto its single instance cloud-based platform since uniting Navicure and ZirMed in 2017. This marks Waystar’s sixth acquisition in the last couple years, as the company rapidly expands within the space (not including their own $2.3B acquisition by two private equity firms last year).

Recent acquisitions include Recondo, a patient estimation and prior authorization technology, PARO, a presumptive charity scoring solution, UPMC’s Ovation, a claims monitoring tool, and Connance, leveraging predictive analytics to offer agency manager, advanced propensity to pay (AP2P), and presumptive charity. Waystar is backed by EQT, Canada Pension Plan Investment Board, and Bain Capital.

NHS Tayside launches app to help IBS sufferers, Thirona launches COVID-19 detection software and more briefs

NHS Tayside launches app to help IBS sufferers, Thirona launches COVID-19 detection software and more briefs

NHS Tayside is launching a new app in partnership with Inhealthcare to help people suffering from IBS. The new app has been funded by the Scottish Government’s Technology Enabled Care Programme and the Modernising Patient Pathways Programme.

The app will help people to track their symptoms over time and identify any changes. They can request extra support from dietitians via the app when needed.

The service aims to reduce the time taken for people to start receiving specialist advice and support. If they have not shown any signs of improvement after four weeks on the service, they can request further support from the dietitian and move onto the next stage in the management pathway.

LIVI AND NORTH TYNESIDE CCG PARTNERSHIP

The UK arm of European digital healthcare provider, Livi, has partnered up with North Tyneside CCG. This move will enable almost a quarter of a million people across the North East of England to have access to a doctor online, via the NHS.

The app enables patients across North Tyneside to request an online video appointment with a GP, seven days a week. Patients can also access medical advice, referrals and prescriptions within the app, without having to de-register from their GP surgery.

North Tyneside CCG’s partnership with Livi, is facilitated under the Alternative Provider Medical Services contract framework.

All 25 practices within North Tyneside have entered into the contract, offering digital appointments via Livi’s app, which is available to download from the App Store and Google Play.

ONLINE STI PLATFORM RECEIVES OVER 5000 REQUESTS

Public Health Wales, the sexual health services of the health boards and Signum Health are delivering a Welsh government funded scheme called Test and Post.

Accessed via the Frisky Wales website, the STI platform was created specifically for Public Health Wales and was piloted before the COVID-19 outbreak, but it has now been rolled out to all health boards in Wales.

Patients fill out a questionnaire online with their details and concerns and can then choose to receive a home test kit which they can use in the privacy of their own home. It offers tests for chlamydia and gonorrhoea and for HIV, syphilis and hepatitis B and C.

In the six weeks since its introduction at the end of May, the platform received 5,139 home kit order requests.

DIGITALHEALTH.LONDON FELLOWSHIP OPENS FOR APPLICATIONS

DigitalHealth.London has opened applications to its Digital Pioneer Fellowship programme, supporting individuals employed by NHS organisations in London to design and lead transformation projects related to digital innovation.

Now in its third consecutive year, the 12-month programme provides up to 30 Fellows with the opportunity to be part of a learning community focused on accelerating the pace of digital transformation within their respective NHS organisations.

The individuals taking part have access to workshops, resources and events throughout the year to share challenges and experience, learn from experts and collaborate to co-design solutions.

ENDER DIAGNOSTICS LAUNCHES SECOND CE-CERTIFIED COVID-19 TEST

Swiss-based company, ender diagnostics, which specialises in the development of molecular biological tests, has launched ender MASS, its second CE-marked test to detect SARS-CoV-2.

ender MASS provides results from a nasopharyngeal swab in 30 minutes and is designed to enable diagnosis for critical settings including schools, manufacturing facilities, travel, hospitals and care homes. It also aims to enable centralised laboratories to accelerate and increase throughput. The test has a US FDA clearance anticipated in September 2020.

THRIVA LAUNCHES THE BLOOD TEST WITH NO BLOOD

Proactive health tech company, Thriva, has launched its service to give people a benchmark on their blood results, without having to do a test.

People are asked to fill in a short questionnaire about their lifestyle habits and medical history. Using machine learning, this information is compared to 800,000+ anonymised blood results to predict results for 12 different tests with 95% accuracy.

Predictions come with an estimated range on where the individual’s result sits — normal, abnormal or optimal. The Predicted Results service has been developed by Thriva’s in-house doctors and data scientists using machine learning and an anonymised data set of tests completed by existing customers.

THIRONA PARTNERS UP WITH SMART REPORTING FOR COVID DETECTION

Dutch AI company, Thirona, has partnered up with German digital health company, Smart Reporting, to launch the SmartCAD | COVID-19 software.

This platform combines Thirona’s CAD4COVID-CT algorithm with the COVID-19 reporting template developed by digital health company, Smart Reporting.

The new system enables direct analysis of chest CT images with CAD4COVID-CT and transfers the results into a structured report.

The output includes a COVID-19 severity score on lung and lobar level, the percentage of abnormalities detected for each lobe and the lungs, and the percentage of lobar emphysema.

PATHWAY THROUGH PAIN MAKES IT INTO NHS APPS LIBRARY

UK-based mobile mental health company, Wellmind Health, has announced that its digital Pain Management Programme (PMP), Pathway through Pain, has successfully completed the assessment process for inclusion in the NHS Apps Library.

The NHS Apps Library helps patients and the public find trusted health and wellbeing digital tools that have been assessed to be clinically safe and secure to use. Pathway through Pain is already provided to patients across the UK through GP Surgeries, Pain Clinics, IAPT and Community Health Services.

Greenway Health develops new telehealth solution to further support healthcare providers in a virtual care environment

Greenway Health develops new telehealth solution to further support healthcare providers in a virtual care environment

Greenway Health, a leading health information technology and services provider, announced the company is also working to develop innovative virtual care solutions that are now essential for today’s ambulatory care practices.

“At the start of the COVID-19 pandemic, we saw a dramatic shift in the way care was being delivered. Providers relied on virtual care to continue seeing patients during periods of shutdown and quarantine,” said Richard Atkin, CEO, Greenway Health. “Just as our healthcare providers have remained committed to patient care, Greenway too, will continue on our mission of enabling ambulatory care practices with the tools they need to improve outcomes, streamline workflows and maintain business continuity.”

As the first tool in its virtual care portfolio, Greenway will be developing and launching Greenway Telehealth™, a secure, HIPAA-compliant solution designed with an easy-to-use interface for both providers and patients. Greenway Telehealth is being designed according to the specific needs of Greenway’s ambulatory care customers, and in particular, practices looking for a sustainable, long-term solution. Greenway Telehealth will remove care delivery barriers, enabling greater provider productivity and improved patient outcomes. Product updates and enhanced electronic health record (EHR) integration will be delivered to customers on a rapid cadence to create additional workflow efficiency. The solution will be powered by Twilio, Greenway’s current Patient Messaging vendor.

 

“We are excited to be moving forward on our path to creating long-term virtual care solutions that can easily be implemented into our customers’ established workflows,” said David Cohen, chief product and technology officer at Greenway. “With these new tools, we are arming today’s providers with the technology they need to continue to deliver quality care to their communities, while also expanding access to care to those who need it most.”

 

ABOUT GREENWAY HEALTH

Improving healthcare through innovation is at the heart of Greenway Health’s work. We provide electronic health record (EHR), practice management and revenue cycle management solutions that help practices in multiple specialties grow profitably, remain compliant, work more efficiently and improve patient outcomes. Our team of clinical, financial and technology experts serve as trusted advisers, committed to our customers’ success. Greenway works with over 55,000 providers across multiple specialties, which translates into millions of lives touched daily by our solutions.

Syapse and FDA Expand Existing Research Collaboration to Rapidly Generate Real-World Evidence Related to COVID-19 and Cancer

Syapse and FDA Expand Existing Research Collaboration to Rapidly Generate Real-World Evidence Related to COVID-19 and Cancer

Syapse®, a real-world data company accelerating the delivery of precision medicine through the Syapse Learning Health NetworkTM, and the U.S. FDA Oncology Center of Excellence (OCE) have expanded an existing multi-year Research Collaboration Agreement (RCA) focused on the use of real-world data (RWD) to support clinical and regulatory decision-making.

“We’re learning quickly how sophisticated analyses of real-world data can provide rapid insights into COVID-19. The FDA’s Oncology Center of Excellence is working to understand COVID-19 in cancer patients using real world data, both through the COVID-19 Evidence Accelerator and a Research Collaboration Agreement with Syapse,” said FDA Principal Deputy Commissioner Amy Abernethy, MD, PhD. “One of our goals is to reduce the burden of lengthy clinical trials on cancer patients and clinical researchers, and we are optimistic that the use of real-world data will help us address important questions more rapidly today, and increasingly so in the future.”

Based on their collaboration efforts, Syapse and the FDA have highlighted results from rapid analyses of real-world data involving cancer patients with COVID-19. Recently, the FDA’s OCE and Syapse presented data at a virtual medical meeting of an analysis of more than 200,000 health records of people living with cancer across two major health systems. Data suggest that patients with cancer who also had COVID-19, compared to those who did not have COVID-19, are more likely to have other health conditions such as kidney failure, obesity and heart disease, in addition to increased rates of hospitalization and invasive mechanical ventilation, along with 16 times greater risk of death. Syapse and its Learning Health Network collaborators presented these findings at the AACR Virtual Meeting on COVID-19 and Cancer on July 22, 2020. The full presentation can be found on the Syapse website.

Thomas Brown, MD, Syapse’s chief medical officer, stated, “Understanding how a patient’s medical history influences their treatment outcomes in a real-world setting is critical for clinicians, researchers and regulatory agencies to appropriately weigh the risk-benefit profile of a drug for a given patient.”

Through a multi-year collaboration, Syapse is partnering with FDA’s Oncology Center of Excellence to:

Investigate methods to derive RWD from multiple sources including electronic health records, registries and molecular data;
Enhance understanding of how patients respond to therapies outside of clinical trials to improve care and outcomes; and
Understand the impact of COVID-19 on cancer care.

About the Syapse Learning Health Network™

This global network of healthcare providers shares real-world data to support clinical decisions and foster collaborations among participants. Healthcare providers, including doctors and nurses, share and learn which cancer treatments produced better real-world outcomes in clinically and molecularly similar patients. Researchers learn from real-world clinical, molecular, treatment and outcomes data. These collaborations are enabled by a secure platform of shared de-identified data that is standardized and normalized across the Learning Health Network and complies with all applicable federal and state data privacy protection regulations.

About Syapse

Syapse works with leading health systems, life sciences companies, and regulators to explore opportunities to use real-world evidence to improve the outcomes of cancer patients. By bringing these organizations together into the Syapse Learning Health NetworkTM, Syapse has built one of the world’s largest networks with a goal to improve outcomes in cancer care through improved precision medicine. Syapse and its partners are working towards a future in which all cancer patients have access to the quality of care they need.

E-commerce Platform Amazon launches Amazon Pharmacy

E-commerce Platform Amazon launches Amazon Pharmacy

E-commerce platform Amazon India has launched Amazon pharmacy making its entry in the online medicine segment. Amazon India first launched this service as a pilot project in Bengaluru. The company will soon launch it in other cities as well. Explain that the demand for medicine has increased during the applicable lockdown and unlock due to the outbreak Covid-19.

Demand for online services increased due to social distancing

To contain the virus, the WHO has given the new norm of social distancing, that everyone is familiar with till now. Due to social distancing, customers are now giving priority to the online consultation, treatment, medical tests and delivery of medicines. Meanwhile, demand for online services has increased with startups such as Practo, NetMeds, 1mg, Pharma-Easy and Medlife.

Committed to meeting customer needs

An Amazon India spokesperson said on Thursday that we are committed to meet the needs of our customers. We are opening our pharmacy in Bengaluru. This will enable customers to order prescription-based medicines right from home. He said that this facility of the company would be helpful for the customers in the current crisis. Through this service, they will be made available through medicines, basic health devices and Ayurveda Medication Certified Sellers.

India’s digital health market to be $ 4.5 billion

According to RedSeer Consulting, India’s digital health market will reach $ 4.5 billion in this financial year. Whereas in FY15 it was only $ 1.2 billion. The consultancy has increased its estimate to 20 billion dollars by 2025. Before the Corona period, this estimate was only $ 19 billion. Medicine delivery will now expand to a larger share of the online market.

600 per cent increase in online consultancy

People are taking all kinds of medicines or vitamins in Corona at the moment to increase their immunity. Also, people are getting treatment for diseases through online consultations. This has led to increased demand for online medicines. E-Health Platform Practo Technology has registered a growth of nearly 600 per cent in online consultancy.

Allscripts enables independent software developers to develop healthcare IT services

Allscripts enables independent software developers to develop healthcare IT services

Allscripts, a global leader in healthcare IT, cultivates a community-oriented approach to healthcare technology software development via its electronic medical record, Allscripts Sunrise™. The open platform provides its users the flexibility to respond swiftly to the changing needs of the healthcare industry, such as with the COVID-19 pandemic which is redefining the approach to patient care. Independent developers and healthcare providers can collaborate through the open ecosystem to solve healthcare challenges like those presented by the pandemic as they develop, building out capabilities on Sunrise to support responsive care.

With nearly 200 apps available through the Allscripts Developer Programme, Allscripts currently partners with approximately 370 companies and more than 7,000 registered developers. 300 of its clients are developing with the company, with more than 2,000 activations of Allscripts Developer Programme solutions.

This was made evident at the Allscripts Asia 2020 Innovators Summit held on 16 July, which promoted familiarity with the Allscripts Developers Programme, illustrating how software developers can strengthen support for the healthcare system with their expertise. By registering to the Allscripts Developers Programme for free, independent software developers can access the resources needed to build integrative capabilities for the Sunrise platform. The event saw third party developers coming together virtually from all over the region to broaden their knowledge of how to work with one of the largest communities in healthcare.

“The current pandemic response is a driving force for increased capacity requirements and optimised workflows in healthcare services, and this illustrates the adaptability healthcare IT solutions need to be capable of in order to effectively support clinical workflows,” said Alan Fowles, President of Allscripts Global. “Not only do healthcare providers utilising Sunrise have the flexibility to optimise their digital processes to reflect patient needs, independent developers can use their skill set to help build out capabilities that ease the burden on clinicians and support healthcare workers.”

With a comprehensive open platform that connects all aspects of care, including acute, ambulatory, surgical, pharmacy, radiology and laboratory services, the Allscripts Sunrise ecosystem has been adopted across a range of hospitals in Singapore, including SingHealth, Singapore’s largest public healthcare cluster. The EMR system is used in its network of acute and community hospitals, specialist centres and polyclinics. The platform acts as an information hub across the healthcare system that unifies all units connected to it and has made it possible to review clinician notes and patient care plans, simultaneously across the various entities. The open architecture capabilities of the Sunrise ecosystem empowers healthcare providers like SingHealth to take capability expansions into their own hands and build out functionality at pace as needed, co-innovating with third party developers.

Recognized as an industry leader in healthcare technology, Allscripts is constantly working to expandhdi its offering and its community of partners and developers, innovating to support healthcare providers in delivering better, more responsive patient care. Most recently, it was announced that Allscripts and Microsoft have extended their strategic alliance to transform cloud-based health IT solutions. The five-year extension will support Allscripts’ cloud-based Sunrise electronic health record, making Microsoft the cloud provider for the solution and opening up co-innovation opportunities to help transform healthcare with smarter, more scalable technology. Among other added benefits, the cloud-based Sunrise solution will include a marketplace that enables healthcare apps and third parties to easily integrate with a hospital EMR. Allscripts clients should expect to see these updates by the end of 2020.

PocketPills Announces Partnership with BioScript Solutions, Expanding Access to Specialty Medication for Canadians

PocketPills Announces Partnership with BioScript Solutions, Expanding Access to Specialty Medication for Canadians

PocketPIlls, Canada’s first digital full-service pharmacy, announces partnership with BioScript Solutions, an organization dedicated to providing full-service, specialty care solutions. Together, PocketPills and BioScript Solutions will offer convenient access and delivery of specialty medications to Canadians from coast to coast.

While insurers were previously required to seek separate solutions for specialty medication, the partnership with BioScript Solutions allows PocketPills to be a full-service digital pharmacy, offering maintenance medications along with a full range of specialty medications. The integration will provide insurers, employers and consumers with cost-effective and convenient solutions for all medication types; in addition to access to pharmacists via live chat or SMS, and free delivery of medication.

“We’re thrilled to bring convenient access of specialty medication to more Canadians than ever through our partnership with BioScript Solutions” said Raj Gulia, CEO of PocketPills. PocketPills has never been prouder to provide free doorstep delivery of medication and virtual access to pharmacists throughout all of Canada.

Headquartered in Surrey, BC, PocketPills allows Canadians to fill their prescriptions online, with medications delivered to their doorstep for free. Members can connect with their pharmacists on live chat or SMS, getting the information they need at their fingertips. Medication management is simplified, with prescription doses pre-sorted by dose, date and time into individual PocketPacks. By leveraging technology-driven workflow automation, PocketPills is able to reduce the cost of operations, passing savings to the member and the plan sponsor through low dispensing fees and free home delivery.

With an ever-increasing portfolio of service offerings that include a nationwide network of specialty pharmacies and over 100 nurse-led clinics, BioScript Solutions supports patients with chronic illnesses and rare diseases by providing access to complex drug therapies and services that optimize health outcomes.

“Our mission is to make access to specialty care as simple as possible while focusing on improved clinical outcomes,” said Andrew Steeves, co-founder of BioScript Solutions.” In today’s world, virtual access to healthcare is a necessity for everyone. We’re excited to be expanding our solutions by partnering with PocketPills.”

About PocketPills

By combining technology and personalized service, PocketPills is improving the way that prescriptions are filled, delivered, and managed. Established by two pharmacists and an engineer in 2018, PocketPills was formed with the vision of simplifying medication management. No more sorting pills, waiting in line, or chasing refills–low dispensing fees and free delivery makes medications affordable, and PocketPills’ platform and app help you take your medications on time, as prescribed.

About BioScript Solutions

BioScript Solutions® is committed to helping people with chronic illnesses achieve the best possible health outcomes. With our total care approach, we simplify access to complex drug therapies and deliver full-service specialty care solutions at every stage of the patient’s treatment journey. Through our specialty pharmaceutical distribution, pharmacies, patient support programs and clinical services, BioScript has the capability to manage the needs of manufacturers, payors, prescribers, and health care practitioners across Canada ? today, and tomorrow.

Philips launches Rapid Equipment Deployment Kit to COVID-19 response

Philips launches Rapid Equipment Deployment Kit to COVID-19 response

Royal Philips, a global leader in health technology, introduced its Rapid Equipment Deployment Kit for ICU ramp-ups, allowing doctors, nurses, technicians and hospital staff to quickly support critical care patient monitoring capabilities during the COVID-19 pandemic. Currently successfully in use in the first health systems across the US, the Rapid Equipment Deployment Kit combines Philips advanced patient monitoring technology with predictive patient centric algorithms enabling care teams to quickly scale up critical care patient monitoring capabilities within a few hours [2]. As health systems in the U.S. continue to experience surges in critical care and emergency care demand related to the COVID-19 crisis, the kit provides hospitals a way to quickly and easily expand their critical care capacity.

Innovative approach to help manage capacity surge in the ICU
The Philips Rapid Equipment Deployment Kit is a fully configured and ready-to-deploy ICU patient monitoring solution, which includes 20 ICU monitors, 20 measurement servers and one central management monitoring station. The kits are pre-built, pre-configured and pre-packed into sturdy cases that can elevate a hospital’s general care area to a critical care level in a matter of hours [3]. Kits are complete with step-by-step instructions allowing the pre-configured system to be deployed by hospital staff, with remote technical and clinical support from Philips. Kits can be transferred from hospital to hospital as needed. Once a crisis/surge passes, the kits are disinfected, packed up and stored to have available in preparation for future emergencies.

“The current health crisis has demonstrated a clear need for us to deliver innovative solutions to our customers that provide a complete critical care monitoring solution with all of the equipment they require on demand. This eliminates the need to source and configure individual pieces of high-demand equipment during a crisis,” said Peter Ziese, General Manager of Monitoring Analytics at Philips. “To help ensure economical and more efficient use of hospital resources, the Rapid Equipment Deployment Kits provide the speed, flexibility and ease of implementation for advanced critical care patient monitoring that many of our customers must have during this most pressing time.”

Philips critical care patient monitoring solutions
In June, Philips announced it had received Emergency Use Authorization from the FDA for Philips’ IntelliVue Patient Monitors MX750/MX850 and its IntelliVue Active Displays AD75/AD85, for use in the US during the COVID-19 health emergency [4]. These patient monitoring solutions support infection-control protocols and remotely provide critical patient information when caring for hospitalized COVID-19 patients. The MX750 and MX850 monitors are the latest additions to Philips’ portfolio of integrated patient monitoring solutions to help support improved clinical and operational workflows. Updated features, include enhancements to monitor and assess clinical and network device performance, and additional functionalities to strengthen cybersecurity. Visit Philips critical care patient monitoring for more information on the Rapid Equipment Deployment Kits in the US market and Philips full suite of critical care patient monitoring solutions.

Philips COVID-19 solutions portfolio

Philips has a comprehensive portfolio of services and solutions to help support the delivery of high-quality care to COVID-19 patients. Solutions include secure, connected and intelligent approaches to diagnosis, treatment and predictive monitoring in the hospital, plus screening, remote patient monitoring and care at home. With healthcare under more pressure than ever before, Philips’ telehealth and AI-enabled data analytics can help support workflows, facilitate remote collaboration and optimize resources. Philips’ COVID-19-related solutions are designed for rapid deployment and scalability. For more information on how Philips is addressing COVID-19 globally, please visit the Philips centralized COVID-19 hub.

About Royal Philips

Royal Philipsis a leading health technology company focused on improving people’s health and enabling better outcomes across the health continuum from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips generated 2019 sales of EUR 19.5 billion and employs approximately 81,000 employees with sales and services in more than 100 countries.

1...576577578...1,125Page 577 of 1,125

About us

Hospital & healthcare Management is a leading B2B arena designed for the healthcare sector, it allow members to reach both ends of the healthcare facility procurement chain. . . Read More

Subscribe us

System

Resources

Archive Links

Subscribe

Copyright © 2008 - 2026 Hospital & Healthcare Management. All rights reserved. Publication of Leo Marcom Pvt Ltd.

Translate »